Fate Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:F6T Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
10 Jan 25Sell€9,057Jerome BressiIndividual5,980€1.51
10 Jan 25Sell€13,099Bahram ValamehrIndividual8,705€1.50
10 Jan 25Sell€8,563Cindy TahlIndividual5,654€1.51
20 Dec 24Buy€641,836Redmile Group, LLCCompany397,964€1.61
20 Dec 24Sell€550,986Redmile Group, LLCCompany341,633€1.61

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of F6T?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,635,9071.43%
General Public17,071,85014.9%
Hedge Funds20,667,45918%
Institutions75,257,80665.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 74.44% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.2%
Redmile Group, LLC
12,872,946€14.2m0%1.17%
9.32%
BlackRock, Inc.
10,681,779€11.8m-2.37%no data
8.99%
The Vanguard Group, Inc.
10,310,453€11.4m-0.22%no data
6.8%
Schonfeld Strategic Advisors LLC
7,794,513€8.6m0%0.05%
3.74%
Citadel Advisors LLC
4,289,159€4.7m-2.12%no data
2.95%
Johnson & Johnson Innovation - JJDC, Inc.
3,379,064€3.7m0%1.18%
2.84%
Baker Bros. Advisors LP
3,258,402€3.6m0%0.03%
2.73%
JP Morgan Asset Management
3,129,763€3.5m108%no data
2.26%
Dimensional Fund Advisors LP
2,591,558€2.9m-10.6%no data
2.19%
Vestal Point Capital, LP
2,515,850€2.8m2.06%0.2%
2.04%
Goldman Sachs Group, Investment Banking and Securities Investments
2,337,326€2.6m-1.79%no data
1.98%
Geode Capital Management, LLC
2,269,609€2.5m1.91%no data
1.94%
Morgan Stanley, Investment Banking and Brokerage Investments
2,221,295€2.5m-14.8%no data
1.92%
Jacobs Levy Equity Management Inc
2,203,323€2.4m38.8%0.01%
1.84%
State Street Global Advisors, Inc.
2,110,065€2.3m-5.26%no data
1.69%
Citigroup Inc.,Banking and Securities Investments
1,937,133€2.1m148%no data
1.63%
Tang Capital Management, LLC
1,867,773€2.1m0.64%0.1%
1.47%
OrbiMed Advisors LLC
1,680,580€1.9m0%0.03%
1.35%
UBS Asset Management AG
1,551,081€1.7m40.6%no data
1.29%
Acadian Asset Management LLC
1,473,792€1.6m0%no data
1.24%
Woodline Partners LP
1,424,167€1.6m0.1%0.01%
1%
Monaco Asset Management S.A.M.
1,149,708€1.3m251%0.6%
0.69%
Northern Trust Global Investments
794,973€877.4k-1.31%no data
0.69%
Two Sigma Advisers, LP
787,000€868.7k-4.96%no data
0.61%
Charles Schwab Investment Management, Inc.
703,825€776.8k-8.63%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/21 13:29
End of Day Share Price 2025/05/21 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Fate Therapeutics, Inc. is covered by 28 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jack AllenBaird
Peter LawsonBarclays
James BirchenoughBMO Capital Markets U.S. (Historical)